Maintaining your independence in biotechnology

Mergers and acquisitions are regular events for biotechnology companies. I have often been asked if being acquired is a goal for biotechnology companies, and if it is seen as a ‘good’ or a ‘bad’ thing. The outlook on merging with another company, or being acquired, is really just a matter of timing. As I describe […]


Patient access to innovation: Biopharmaceuticals, 4th hurdles and socioeconomic issues

This paper is part of the free Open Access archive of the Journal of Commercial Biotechnology
Patient access to innovation: Biopharmaceuticals, 4th hurdles and socioeconomic issues
Go to paperABSTRACT: Biopharmaceuticals and innovative therapeutic…


Adventures in Data Wrangling

I will be giving a talk on September 10th at George Washington University on two recent data analytics projects: Firstly, I will present Scientific American Worldview, a global biotechnology ranking I developed six years ago and have managed since. The primary challenges in developing Worldview have been ensuring that the product is accessible to a […]


Media coverage and biotechnology IPOs: Some Australian evidence

This paper is part of the free Open Access archive of the Journal of Commercial Biotechnology
Media coverage and biotechnology IPOs: Some Australian evidence
Go to paperABSTRACT: This paper analyses Australian biotechnology initial public offerin…


Transfer to Africa of the resources and rewards from biotechnology: The need for a participatory approach

This paper is part of the free Open Access archive of the Journal of Commercial Biotechnology
Transfer to Africa of the resources and rewards from biotechnology: The need for a participatory approach
Go to paperABSTRACT: The low adoption rate of n…


Biotechnology in Countries Starting with “I” – Part 6: Iceland

This is a guest post from Susan K Finston, President of Finston Consulting. Do you have a response to Susan’s post? Respond in the comments section below. Once again we have reached the dog-days of summer in Washington DC, when it is nice to day-dream about biotechnology in cooler climates. There may be no better destination […]


Leadership Skills in the Biotech Start-Up

This is a guest post from Isabela Oliva. Do you have a response to Isabela’s post? Respond in the comments section below. How to survive the expected and unexpected challenges of the start-up lifecycle in the biotechnology business A major difference between biotechnology and information technology ventures is the time it takes to bring a product […]